Antibe Therapeutics
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
15 Prince Arthur Ave, Toronto, Ontario, ...Phone Number
(416) 922-3460Website
www.antibethera.comRevenue
$7.6 MillionStock Symbol
ATEIndustry
About Antibe Therapeutics
Is Antibe Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Antibe Therapeutics has new funding data
Check if Antibe Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Antibe Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Antibe Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Antibe Therapeutics
Earning: See what the market has to say on Antibe Therapeutics recently announced quarterly report
Product Launch: Get notified when Antibe Therapeutics launches new products
Click to see if Antibe Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Antibe Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Antibe Therapeutics
Compare insights from companies similar to Antibe Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Antibe Therapeutics
Company Profile Activity
Activity Insights
Antibe Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Antibe Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Antibe Therapeutics.
Antibe Therapeutics Tech Stack
A closer look at the technologies used by Antibe Therapeutics
Most Recent Scoops
Antibe Therapeutics News & Media
Sun Pharma unit Taro to acquire 100% stake in Antibe Therapeutics for an undisclosed sum
Since the Ontario Court is overseeing the divestment of Antibe, the court-appointed receiver has indicated that acquisition consideration should not be disclosed until the closing of the transaction. Sun Pharma will update the consideration to stock exchanges once the transaction is completed.NOTICE TO CLAIMANTS OF ANTIBE THERAPEUTICS INC. ("ANTIBE")
RE: NOTICE OF CLAIMS PROCEDURE FOR ANTIBE TORONTO, July 12, 2024 /PRNewswire/ - PLEASE TAKE NOTICE that this Notice to Claimants is being published pursuant to an order of the Ontario Superior Court of Justice (Commercial List) dated June 24, 2024 (the "Claims Procedure Order") in the...Antibe Announces Appointment of Receiver
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Announces Appointment of ReceiverAntibe Provides Update on CCAA Proceedings
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Provides Update on CCAA Proceedings
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Antibe Therapeutics
Founded in 2009, Antibe Therapeutics is a pharmaceutical development company, originates, develops, and out-licenses patent novel therapeutics and medical devices in the areas of pain, inflammation, and regenerative medicine in Canada, Europe, the United States, and internationally. Its drugs are designed to prevent the gastrointestinal damage and... Read More